Stay updated on MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Sign up to get notified when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.

Latest updates to the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page
- Check2 days agoChange DetectedNew revision entry v3.3.4 was added and the previous revision v3.3.3 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry (v3.3.3) is added, and the HHS Vulnerability Disclosure link along with the prior revision (v3.3.2) are removed. These updates are administrative and do not affect the study information.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision history shows addition of v3.3.2 and removal of v3.2.0, reflecting routine record-keeping rather than changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange Detected- Removed the site-wide banner about a lapse in government funding and NIH/OPM operating status from the page. The core study history content and controls remain unchanged.SummaryDifference0.8%

- Check81 days agoChange DetectedRecord history shows progressive updates: 2021-12-09 adds Study Status and Contacts/Locations. 2022-01-13 and 2022-04-12 update Recruitment Status and Study Status; 2024-01-25 adds an Oversight entry.SummaryDifference0.1%

- Check102 days agoChange DetectedUpgrade notice and new version v3.2.0 added; previous version v3.1.0 removed.SummaryDifference12%

Stay in the know with updates to MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.